what tier are glp 1 drugs MCT2D What are GLP-1s? | Mendinground
Description
On average the reported weight loss is between 3 and 5.5 lbs (1.5 to 2.5 kg)
Mol Endocrinol 2001
Note: animal studies indicate that high doses of DPP-4 inhibitors & GLP-1 agonists cause expansion of cells of the pancreatic ductal glands and can cause premalignant pancreatic intraepithelial lesions (PanIN) that have the potential to progress to pancreatic adenocarcinoma
doi: 10.4062/biomolther.2024.188
& Biessels, G
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
